- Home
- CHEC vs ENLV Comparison
CHEC vs ENLV Comparison
Compare CHEC & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$4.13
Company Overview
Basic Information| Metric | CHEC | ENLV |
|---|---|---|
| Founded | 2024 | 2005 |
| Country | Singapore | Israel |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 175.5M | 149.0M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | CHEC | ENLV |
|---|---|---|
| Price | $10.19 | $4.13 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | 6.7K | ★ 263.7K |
| Earning Date | 01-01-0001 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.91 | $0.43 |
| 52 Week High | $10.56 | $7.64 |
Technical Indicators
Market Signals| Indicator | CHEC | ENLV |
|---|---|---|
| Relative Strength Index (RSI) | 59.39 | 57.97 |
| Support Level | $10.15 | $0.79 |
| Resistance Level | $10.47 | $7.64 |
| Average True Range (ATR) | 0.01 | 0.61 |
| MACD | -0.00 | -0.13 |
| Stochastic Oscillator | 66.67 | 50.92 |
Price Performance
Historical Comparison CHEC
ENLV
About CHEC Chenghe Acquisition III Co. Class A Ordinary Share
Chenghe Acquisition III Co is blank check company.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.